| Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer (NCT00052585) | National Cancer Institute (NCI) | 2002-10-01 |
| Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer (NCT00049166) | National Cancer Institute (NCI) | 2002-10-01 |
| Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors (NCT00052780) | National Cancer Institute (NCI) | 2002-10-01 |
| Validation of Self-Reported Needle Sharing Among Injection Drug Users (NCT00341081) | National Cancer Institute (NCI) | 2002-10-01 |
| Gefitinib in Treating Patients With Cervical Cancer (NCT00049556) | National Cancer Institute (NCI) | 2002-10-01 |
| Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors (NCT00054548) | National Cancer Institute (NCI) | 2002-10-01 |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia (NCT00022737) | National Cancer Institute (NCI) | 2002-10-01 |
| Genes Involved in Resistance or Susceptibility to Hepatitis B Virus (NCT00342186) | National Cancer Institute (NCI) | 2002-09-27 |
| Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas (NCT00043979) | National Cancer Institute (NCI) | 2002-09-19 |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery (NCT00049543) | National Cancer Institute (NCI) | 2002-09-01 |
| Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma (NCT00049387) | National Cancer Institute (NCI) | 2002-09-01 |
| Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00047203) | National Cancer Institute (NCI) | 2002-09-01 |
| Risk Factors for Non-HIV-Related Kaposi s Sarcoma (NCT00339326) | National Cancer Institute (NCI) | 2002-09-01 |
| Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer (NCT00049283) | National Cancer Institute (NCI) | 2002-09-01 |
| Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT02227901) | National Cancer Institute (NCI) | 2002-09-01 |
| Oxaliplatin in Treating Patients With Liver Cancer (NCT00052364) | National Cancer Institute (NCI) | 2002-09-01 |
| FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia (NCT00053963) | National Cancer Institute (NCI) | 2002-09-01 |
| Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia (NCT00030394) | National Cancer Institute (NCI) | 2002-09-01 |
| Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer (NCT00052338) | National Cancer Institute (NCI) | 2002-09-01 |
| Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer (NCT00052351) | National Cancer Institute (NCI) | 2002-09-01 |
| Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia (NCT00049582) | National Cancer Institute (NCI) | 2002-09-01 |
| Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides (NCT00052377) | National Cancer Institute (NCI) | 2002-09-01 |
| Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer (NCT00045227) | National Cancer Institute (NCI) | 2002-08-01 |
| Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00047047) | National Cancer Institute (NCI) | 2002-08-01 |
| Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia (NCT00047190) | National Cancer Institute (NCI) | 2002-08-01 |
| Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer (NCT00047307) | National Cancer Institute (NCI) | 2002-08-01 |
| UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00042861) | National Cancer Institute (NCI) | 2002-08-01 |
| National Lung Screening Trial (NLST) Screening (NCT00047385) | National Cancer Institute (NCI) | 2002-08-01 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer (NCT00021060) | National Cancer Institute (NCI) | 2002-08-01 |
| Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer (NCT00045331) | National Cancer Institute (NCI) | 2002-08-01 |
| Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma (NCT00045110) | National Cancer Institute (NCI) | 2002-08-01 |
| E7389 in Treating Patients With Advanced Solid Tumors (NCT00047034) | National Cancer Institute (NCI) | 2002-08-01 |
| Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer (NCT00045188) | National Cancer Institute (NCI) | 2002-08-01 |
| Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction (NCT00047346) | National Cancer Institute (NCI) | 2002-08-01 |
| Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer (NCT00052559) | National Cancer Institute (NCI) | 2002-08-01 |
| Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00049088) | National Cancer Institute (NCI) | 2002-08-01 |
| Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed (NCT00047333) | National Cancer Institute (NCI) | 2002-08-01 |
| Collection of Blood, Bone Marrow, Tumor or Tissue Samples (NCT00043615) | National Cancer Institute (NCI) | 2002-07-29 |
| Collection of Blood From Patients With Cancer (NCT00034216) | National Cancer Institute (NCI) | 2002-07-16 |
| HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS) (NCT00339430) | National Cancer Institute (NCI) | 2002-07-15 |
| Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer (NCT00039676) | National Cancer Institute (NCI) | 2002-07-08 |
| Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer (NCT00055861) | National Cancer Institute (NCI) | 2002-07-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00046917) | National Cancer Institute (NCI) | 2002-07-01 |
| Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy (NCT00025155) | National Cancer Institute (NCI) | 2002-07-01 |
| Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer (NCT00040222) | National Cancer Institute (NCI) | 2002-07-01 |
| Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas (NCT00042991) | National Cancer Institute (NCI) | 2002-07-01 |
| Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma (NCT00040352) | National Cancer Institute (NCI) | 2002-07-01 |
| Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00004856) | National Cancer Institute (NCI) | 2002-07-01 |
| Survey of Prostate Cancer in Accra, Ghana (NCT00339534) | National Cancer Institute (NCI) | 2002-06-26 |
| Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors (NCT00045201) | National Cancer Institute (NCI) | 2002-06-13 |
| Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer (NCT00039624) | National Cancer Institute (NCI) | 2002-06-03 |
| Gefitinib in Treating Children With Refractory Solid Tumors (NCT00040781) | National Cancer Institute (NCI) | 2002-06-01 |
| A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS) (NCT00045396) | National Cancer Institute (NCI) | 2002-06-01 |
| Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer (NCT00040365) | National Cancer Institute (NCI) | 2002-06-01 |
| UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma (NCT00045500) | National Cancer Institute (NCI) | 2002-06-01 |
| Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer (NCT00042952) | National Cancer Institute (NCI) | 2002-06-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery (NCT00043121) | National Cancer Institute (NCI) | 2002-06-01 |
| Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery (NCT00041197) | National Cancer Institute (NCI) | 2002-06-01 |
| Tipifarnib in Treating Patients With Myelodysplastic Syndromes (NCT00005845) | National Cancer Institute (NCI) | 2002-06-01 |
| Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma (NCT00031915) | National Cancer Institute (NCI) | 2002-06-01 |
| Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer (NCT00045526) | National Cancer Institute (NCI) | 2002-06-01 |
| Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma (NCT00036855) | National Cancer Institute (NCI) | 2002-06-01 |
| Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer (NCT00041041) | National Cancer Institute (NCI) | 2002-06-01 |
| Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT00027690) | National Cancer Institute (NCI) | 2002-06-01 |
| Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma (NCT00017264) | National Cancer Institute (NCI) | 2002-06-01 |
| Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies (NCT00037817) | National Cancer Institute (NCI) | 2002-05-17 |
| Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer (NCT00033137) | National Cancer Institute (NCI) | 2002-05-13 |
| Influence of Corn Farming on the Immune System (NCT00342121) | National Cancer Institute (NCI) | 2002-05-03 |
| Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood (NCT00030667) | National Cancer Institute (NCI) | 2002-05-01 |
| Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor (NCT00039585) | National Cancer Institute (NCI) | 2002-05-01 |
| Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00045097) | National Cancer Institute (NCI) | 2002-05-01 |
| A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas (NCT00036569) | National Cancer Institute (NCI) | 2002-05-01 |
| Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer (NCT00042835) | National Cancer Institute (NCI) | 2002-05-01 |
| Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (NCT00039611) | National Cancer Institute (NCI) | 2002-05-01 |
| Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00040794) | National Cancer Institute (NCI) | 2002-05-01 |
| BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00040755) | National Cancer Institute (NCI) | 2002-05-01 |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00042874) | National Cancer Institute (NCI) | 2002-05-01 |
| Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung (NCT00039182) | National Cancer Institute (NCI) | 2002-05-01 |
| EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer (NCT02154399) | National Cancer Institute (NCI) | 2002-05-01 |
| Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer (NCT00041340) | National Cancer Institute (NCI) | 2002-05-01 |
| Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00042809) | National Cancer Institute (NCI) | 2002-05-01 |
| Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer (NCT00041106) | National Cancer Institute (NCI) | 2002-05-01 |
| Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols (NCT00035373) | National Cancer Institute (NCI) | 2002-04-19 |
| Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3) (NCT00340548) | National Cancer Institute (NCI) | 2002-04-09 |
| Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer (NCT00039104) | National Cancer Institute (NCI) | 2002-04-01 |
| Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00040768) | National Cancer Institute (NCI) | 2002-04-01 |
| Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer (NCT00039455) | National Cancer Institute (NCI) | 2002-04-01 |
| CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma (NCT00033267) | National Cancer Institute (NCI) | 2002-04-01 |
| Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00033332) | National Cancer Institute (NCI) | 2002-04-01 |
| Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00039377) | National Cancer Institute (NCI) | 2002-04-01 |
| Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer (NCT00036751) | National Cancer Institute (NCI) | 2002-04-01 |
| Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain (NCT00032097) | National Cancer Institute (NCI) | 2002-04-01 |
| Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix (NCT00025233) | National Cancer Institute (NCI) | 2002-04-01 |
| Imatinib Mesylate in Treating Patients With Myelofibrosis (NCT00039416) | National Cancer Institute (NCI) | 2002-04-01 |
| UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer (NCT00039403) | National Cancer Institute (NCI) | 2002-04-01 |
| Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT00039390) | National Cancer Institute (NCI) | 2002-04-01 |
| Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00022659) | National Cancer Institute (NCI) | 2002-04-01 |
| Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00039117) | National Cancer Institute (NCI) | 2002-04-01 |
| Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor (NCT00028002) | National Cancer Institute (NCI) | 2002-03-31 |
| Ketoconazole Plus Docetaxel to Treat Prostate Cancer (NCT00032825) | National Cancer Institute (NCI) | 2002-03-19 |